EMBO Members are instrumental in the running of the organization’s programmes. Four members talked to Kathy Weston about why they agreed to be part of an EMBO Committee and what they personally gained from it.
EMBO Members are instrumental in the running of the organization’s programmes. Four members talked to Kathy Weston about why they agreed to be part of an EMBO Committee and what they personally gained from it.
EMBO Members are instrumental in the running of the organization’s programmes. Four members talked to Kathy Weston about why they agreed to be part of an EMBO Committee and what they personally gained from it.
EMBO is pleased to announce that eleven life scientists have been selected to receive Installation Grants, which will support them in establishing independent laboratories in the Czech Republic, Poland, Portugal and Turkey.
Although the United Kingdom is leaving the European Union today, scientists based in the UK will continue to have access to all EMBO Programmes and activities.
EMBO Molecular Medicine (EMM), one of five journals published by EMBO Press, was established in 2009 for the purpose of publishing the best work at the interface between clinical research and molecular cell biology. In its tenth anniversary year, we highlight ten characteristics that have helped to establish EMM in the world of scientific publishing.
Multi-journal partnership aims to accelerate scientific publishing by offering journal-independent peer review
Nine life scientists join the new EMBO Programme in its first year
MALT1 blockers have long been in clinical use for the treatment of blood cancers. A study suggests that these drugs could potentially also be developed as a treatment option for glioblastoma, the most common and lethal type of brain tumour.
EMBO Press is pleased to announce the appointment of systems biologist M. Madan Babu as the new Chief Editor of Molecular Systems Biology.
